GL1X · GenesisL1 explorer

MolNFT v1 · #152874 · protein

Structural insights into mycobacterium tuberculosis CLPP1P2 inhibition by cediranib: implications for developing antimicrobial agents targeting clp protease

6IW7 · ATP-dependent clp protease proteolytic subunit 2: “Structural insights into mycobacterium tuberculosis CLPP1P2 inhibition by cediranib: implications for…”. X-ray diffraction, 2 ligands (BEZ, AV3), 20 pockets (best druggability…

PDB
6IW7
Type
protein
Length
2,621 residues
Chains
28
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ATP-dependent clp protease proteolytic subunit 2; ATP-dependent clp protease proteolytic…
EC
3.4.21.92
UniProt
P9WPC2, P9WPC4
Ligands
BEZ, AV3
Pockets
20 · best druggability 0.74

Structure

x-ray diffraction · 8 distinct chains · 46% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AATP-dependent clp protease proteolytic subunit 2 (EC 3.4.21.92)protein19443% helix, 26% strandP9WPC2
BATP-dependent clp protease proteolytic subunit 1 (EC 3.4.21.92)protein17750% helix, 23% strandP9WPC4
C, F, HATP-dependent clp protease proteolytic subunit 2 (EC 3.4.21.92)protein19643% helix, 28% strandP9WPC2
D, I, KATP-dependent clp protease proteolytic subunit 1 (EC 3.4.21.92)protein17549% helix, 25% strandP9WPC4
JATP-dependent clp protease proteolytic subunit 2 (EC 3.4.21.92)protein19543% helix, 28% strandP9WPC2
L, EATP-dependent clp protease proteolytic subunit 2 (EC 3.4.21.92)protein19344% helix, 28% strandP9WPC2
M, N, GATP-dependent clp protease proteolytic subunit 1 (EC 3.4.21.92)protein17649% helix, 24% strandP9WPC4
O, P, Q, R, T, U, V, W, X, Z, a, b, d, eBez-leu-leuprotein20% helix, 0% strand—

Ligands and binding sites

  • BEZ · Benzoic acid · ligand · 14 copies · chains J, K, O, P, A, B, Q, R, F, M, T, U, C, D, V, W, H, I, X, Z, E, G, a, b, L, N, d, e
  • AV3 · 4-[(4-fluoro-2-methyl-3H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline · ligand · 7 copies · chains B, K, O, M, D, I, N, d, G, a, X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19420.740.7787BEZ, AV3
28890.730.7788BEZ, AV3
39350.730.7788BEZ, AV3
49350.730.7789BEZ, AV3
59030.720.7787BEZ, AV3

Interfaces

62 interfaces between chains.

  • H–E · 1778 Ų buried · 19 hydrogen bonds · protein-protein
  • A–J · 1767 Ų buried · 22 hydrogen bonds · protein-protein
  • C–H · 1766 Ų buried · 22 hydrogen bonds · protein-protein
  • C–F · 1748 Ų buried · 22 hydrogen bonds · protein-protein
  • A–F · 1686 Ų buried · 24 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 14 covalent (covalent ligand).

Compared structures

  • 6IW7 · structural insights into Mycobacterium tuberculosis ClpP1P2 inhibition by Cediranib… · the same entry in another collection · chain G against G, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.